首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1673044

轉移性黑色素瘤藥物市場：依療法、階段、最終用戶和地區

Metastatic Melanoma Therapeutics Market, By Therapy, By Stages, By End User, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025年全球轉移性黑色素瘤治療市場規模估計為 80億美元，預計到2032年將達到 180.2億美元，2025-2032年的年複合成長率為 12.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	80億美元
歷史資料	2020-2024年	預測期	2025-2032年
預測期：2025-2032年年複合成長率：	12.30％	2032年價值預測	180.2億美元

圖表.2025年轉移性黑色素瘤治療市場佔有率（依地區）

轉移性黑色素瘤是一種危及生命的皮膚癌，當黑色素瘤皮膚癌擴散到身體其他器官時就會發生。根據最近的研究，2020年全球將報告超過200,000例黑色素瘤新病例，使其成為最常見的癌症之一。全球黑色素瘤發生率的不斷上升，加上轉移性黑色素瘤的高死亡率，促使人們廣泛研究針對此適應症的新治療方法。近年來，幾種標靶治療和免疫療法藥物已被核准用於治療轉移性黑色素瘤。然而，對於更有效、更安全的治療方案以改善臨床結果的需求仍然存在很大差距。

市場動態：

全球轉移性黑色素瘤藥物市場受到全球範圍內黑色素瘤發病率上升的推動，這是由於紫外線曝射量增加以及人們對該疾病的認知不斷提高所致。此外，新型標靶治療藥物和免疫查核點抑制劑的持續監管核准進一步擴大市場範圍。然而，先進的標靶治療和免疫療法的高成本仍然是影響其廣泛應用的主要挑戰。此外，現有治療方法的長期使用在反應率和抗藥性的出現方面受到限制。聯合治療等創新治療策略的開發具有巨大潛力，可以滿足當前未滿足的需求並在未來幾年促進市場成長。

本研究的主要特點

本報告對全球轉移性黑色素瘤治療市場進行了詳細分析，並以2024年為基準年，展示了預測期（2025-2032年）的市場規模和年複合成長率。
強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球轉移性黑色素瘤藥物市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行介紹的。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球轉移性黑色素瘤治療藥物市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球轉移性黑色素瘤治療藥物市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 8.00 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.30%	2032 Value Projection:	USD 18.02 Bn

Metastatic melanoma is a life-threatening form of skin cancer that occurs due to the spread of melanoma skin cancer to other organs of the body. According to recent studies, over 200,000 new cases of melanoma were reported globally in 2020, making it one of the most common types of cancer. The rising global incidence of melanoma coupled with the high mortality rate associated with metastatic melanoma has driven extensive research into new therapeutic approaches for this indication. Several targeted therapies and immunotherapy drugs have been approved in recent years for the treatment of metastatic melanoma. However, there remains a significant unmet need for more effective and safer treatment options with improved clinical outcomes.

Market Dynamics:

The global metastatic melanoma therapeutics market is driven by the increasing incidence of melanoma worldwide due to rising UV radiation exposure and growing awareness about the disease. Moreover, continual approvals of novel targeted therapies and immune checkpoint inhibitors by regulatory agencies are further expanding the market scope. However, high costs associated with advanced targeted drugs and immunotherapy treatments remain a major challenge affecting broader adoption. Additionally, limitations in terms of response rate and emergence of resistance pose limitations on the long-term usage of existing therapies. The development of innovative treatment strategies, such as combination therapies, holds significant potential to address the current unmet needs and augment the market growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global metastatic melanoma therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global metastatic melanoma therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amgen, Bristol-Myers Squibb, Roche, Novartis, Merck, and Eli Lilly
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global metastatic melanoma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global metastatic melanoma therapeutics market

Detailed Segmentation-

By Therapy
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Radiation therapy
By Stages
- Stage 0
- Stage I
- Stage II
- Stage III
- Stage IV
By End User
- Hospitals
- Cancer Centers
- Homecare
- Specialty Clinics
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Johnson & Johnson Private Limited
- Sun Pharmaceutical Industries Limited
- Sanofi S.A.
- Bayer AG
- Lilly
- Merck & Co., Inc.
- GSK plc
- Novartis AG
- AbbVie Inc.
- Bausch Health Companies Inc.
- Hoffmann-La Roche Ltd
- Amgen Inc.
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy
- Market Snapshot, By Stages
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Metastatic Melanoma Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Metastatic Melanoma Therapeutics Market, By Therapy, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Targeted therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Radiation therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Metastatic Melanoma Therapeutics Market, By Stages, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Stage 0
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Stage I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Stage II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Stage III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Stage IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Metastatic Melanoma Therapeutics Market, By End User, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cancer Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Homecare
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Metastatic Melanoma Therapeutics Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stages, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Johnson & Johnson Private Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sun Pharmaceutical Industries Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lilly
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bausch Health Companies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
- AstraZeneca PLC
- Daiichi Sankyo Company, Limited

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

轉移性黑色素瘤藥物市場：依療法、階段、最終用戶和地區

Metastatic Melanoma Therapeutics Market, By Therapy, By Stages, By End User, By Geography

市場動態：

本研究的主要特點

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

第4章全球轉移性黑色素瘤藥物市場-冠狀病毒（COVID-19）大流行的影響

第5章 2020-2032年全球轉移性黑色素瘤藥物市場（依療法）（十億美元）

第6章全球轉移性黑色素瘤藥物市場（依階段），2020-2032年（十億美元）

第7章 2020-2032年全球轉移性黑色素瘤藥物市場（依最終用戶）（十億美元）

第8章 2020-2032年全球轉移性黑色素瘤藥物市場（依地區）（十億美元）

第9章競爭格局

第10章分析師建議

第11章調查方法

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Metastatic Melanoma Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Metastatic Melanoma Therapeutics Market, By Therapy, 2020 - 2032, (USD Bn)

6. Global Metastatic Melanoma Therapeutics Market, By Stages, 2020 - 2032, (USD Bn)

7. Global Metastatic Melanoma Therapeutics Market, By End User, 2020 - 2032, (USD Bn)

8. Global Metastatic Melanoma Therapeutics Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Research Methodology

轉移性黑色素瘤藥物市場：依療法、階段、最終用戶和地區

Metastatic Melanoma Therapeutics Market, By Therapy, By Stages, By End User, By Geography

市場動態：

本研究的主要特點

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章 市場動態、法規與趨勢分析

第4章 全球轉移性黑色素瘤藥物市場-冠狀病毒（COVID-19）大流行的影響

第5章 2020-2032年全球轉移性黑色素瘤藥物市場（依療法）（十億美元）

第6章 全球轉移性黑色素瘤藥物市場（依階段），2020-2032年（十億美元）

第7章 2020-2032年全球轉移性黑色素瘤藥物市場（依最終用戶）（十億美元）

第8章 2020-2032年全球轉移性黑色素瘤藥物市場（依地區）（十億美元）

第9章 競爭格局

第10章 分析師建議

第11章 調查方法

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Metastatic Melanoma Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Metastatic Melanoma Therapeutics Market, By Therapy, 2020 - 2032, (USD Bn)

6. Global Metastatic Melanoma Therapeutics Market, By Stages, 2020 - 2032, (USD Bn)

7. Global Metastatic Melanoma Therapeutics Market, By End User, 2020 - 2032, (USD Bn)

8. Global Metastatic Melanoma Therapeutics Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Research Methodology

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

第4章全球轉移性黑色素瘤藥物市場-冠狀病毒（COVID-19）大流行的影響

第6章全球轉移性黑色素瘤藥物市場（依階段），2020-2032年（十億美元）

第9章競爭格局

第10章分析師建議

第11章調查方法